National Institute of Neurological Disorders and Stroke/NIH/DHHS

Funding Organization

Awards Grant

  • 14-3-3 Phosphorylation in Parkinson’s Disease
  • AMPAR Function in Synaptic and Extrasynaptic Membranes
  • Acquired HCN Channelopathies in Cortical Dysplasia
  • Actions of BDNF on Ca2+ Signals in Hippocampal Neurons
  • Adaptive Neuroplasticity Following Central Visual Field Loss in Macular Degeneration
  • Alabama Neuroscience Blueprint Core Center
  • Alabama Neuroscience Blueprint Core Center - Consolidated Core
  • Alabama Neuroscience Blueprint Core Center - Core A
  • Alabama Neuroscience Blueprint Core Center - Core B
  • Alabama Neuroscience Blueprint Core Center - Core D
  • Alabama Neuroscience Blueprint Core Center - Core E
  • Alpha M Beta 2 Integrin Blockade for Acute Inflammatory Neuropathies
  • Alpha-Galactosidase A: A Novel Target for Reducing Alpha-Synuclein Toxicity
  • Alpha-Synuclein Degradation Mechanisms
  • Amino Acid Transport and the Biology of Human Gliomas
  • Amino Acid Transport and the Biology of Human Gliomas
  • Analyses and Applications of GFAP Transcription
  • Astrocytes Are A Primary Target of Neuronal-derived BDNF: A Novel Mechanism for Dysfunction in Rett Syndrome
  • Bcl-X Dependent Neuropathology
  • Biosynthetic Metabolic Pathway Regulation of Glioma Growth
  • Blocking Arsenicals-Induced Cutaneous Injury
  • Border-Associated Macrophages in an Alpha-Synuclein Overabundance Model of Parkinson Disease
  • Brain Mitochondria and Glycogen Synthase Kinase-3beta
  • Brain Tumor Recurrence Via Signals From Vascular Endothelial Cells
  • C-reactive Protein, Autoimmunity, and Inflammation in the Central Nervous System
  • CD11d Antagonism For Chronic Inflammatory Neuropathies
  • CREST-2 Statistical and Data Coordinating Center - (SDCC)
  • Cell-Type Specific Role of the Circadian Molecular Clock in Regulating Hippocampal Physiology and Cognition
  • Cell-based Assays for Identifying Anti-RANK Signaling Agents
  • Center for Glial Biology in Medicine Research Recruitment Core Center
  • Cerebral Hemodynamics And Neurocognition In Severe Acrtic Valve Disease
  • Circadian Dysfunction and GSK3 in Neurodegenerative Disease
  • Circadian Dysfunction and Neurodegenerative Disease
  • Clinical and Neurophysiological Study of Subthalamic Brain Stimulation in PD
  • Consequences of Metabolic Reprogramming by GLUT3 in GBM
  • Cortical Spread of Hippocampal Hyperactivity in Rett Syndrome
  • Cytochrome C Oxidase: Biomarker In Newly Diagnosed Glioblastoma Multiforme
  • Defective Thalamic Projections to Dorsal Striatum in Rett Syndrome
  • Developing Models to Define the Frataxin G130V-Specific Pathogenic Mechanism in Friedreich's Ataxia
  • Developing an Adenoviral Vector Platform for Selective Gene Delivery to Neurons
  • Diagnosis of Parkinson's Disease Using Diffusion Tensor Imaging
  • Donor Innate Lymphocyte Infusion Product for Immunotherapy of Glioblastoma Multiforme
  • Dopaminergic Modulation of Astrocytic Function in the Cerebellum
  • Dysregulation of VEGF RNA Stability in Amyotrophic Lateral Sclerosis
  • Efficacies and Pharmacodynamic Assays for LRRK2 Small-Molecule Inhibitors
  • Efficacies and Pharmacodynamic Assays for LRRK2 Small-Molecule Inhibitors
  • Enhancement of Proteasome Activity for the Treatment of Neurological Disorders
  • Epigenetic Mechanisms in Epilepsy-Related Memory Formation
  • Epigenetic Regulation of Kir4.1 and GLT-1 in Pathophysiology
  • Etiology of Geographic and Racial Differences in Stroke
  • Etiology of Geographic and Racial Differences in Stroke
  • Evaluating the Role of NRG-1 Receptors in MPNST Tumorigenesis
  • Exosome LRRK2 in Predicting Parkinson Disease Phenotypes
  • Experience-Dependent Synaptogenesis In Adult-Generated Neurons
  • Exploring the Contribution of Astrocytes to Huntington Disease
  • Expression Reporter Mice for Non-Invasive Imaging: PGC-1a and Huntington's Disease
  • Expression and Function of SOCS Proteins in Glial Cells - ARRA
  • Extrasynaptic Signaling to Interneuron Networks
  • FGF23: A Novel Biomarker in ALS and More
  • Fibronectin Peptide Antagonism for Chronic Inflammatory Neuropathies
  • Frequency-dependent Modulation of Synaptic Transmission and Plasticity by pH
  • GAA Repeats Induced Epigenetic Silencing in Friedreich's Ataxia
  • GAA Repeats Induced Epigenetic Silencing in Friedrich's Ataxia
  • GABAergic Signaling to Adult-born Neurons from Parvalbumin-expressiing Interneurons
  • GIRK Channel Modulation of SCN Excitability and Circadian Rhythms
  • GSK3 Regulation of Suprachiasmatic Neuronal Excitability and Light Entrainment
  • GSK3: Immunoregulator in Experimental Autoimmune Encephalomyelitis (EAE)
  • Genetic Analysis of Onset Age of Parkinson's Disease
  • Genetic Susceptibility and Epigenetic Modulation in Levodopa Induced Dyskinesia
  • Glioma-Astrocyte Vascular Interactions
  • Glutamate Spillover Transmission in the Cerebellar Cortex
  • Identification of Glucose Transporter 3 Inhibitors for Glioblastoma Treatment
  • Impact of Disordered Mineral Metabolism on Stroke and Cognitive Impairment
  • Inhibitory Neural Circuits in Dentate Function
  • Innate and Adaptive Immunity in Parkinson Disease
  • Innate and Adaptive Immunity in Parkinson Disease
  • Innate and Adaptive Immunity in Parkinson Disease - Core A: Administrative Core
  • Innate and Adaptive Immunity in Parkinson Disease - Core A: Administrative Core
  • Innate and Adaptive Immunity in Parkinson Disease - Core B: Clinical Research Core
  • Innate and Adaptive Immunity in Parkinson Disease - Core C: Animal Core
  • Innate and Adaptive Immunity in Parkinson Disease - Project 1: Role of Innate Immune Cells in Human Parkinson Disease
  • Innate and Adaptive Immunity in Parkinson Disease - Project 1: PD-Linked Susceptibilities in Myeloid-Cell CNS Infiltration
  • Innate and Adaptive Immunity in Parkinson Disease - Project 2
  • Innate and Adaptive Immunity in Parkinson Disease - Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD
  • Innate and Adaptive Immunity in Parkinson Disease - Project 3: LRRK2 Mediated Macrophage Responses in PD
  • Innate and Adaptive Immunity in Parkinson Disease - Project 3: Role of Myeloid Cells in Human Parkinson Disease
  • Ion Channels and Their Functions at the Node of Ranvier of Mammalian Somatosensory Afferent Fibers
  • LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease
  • Light-Induced Genetic Alterations Within Single Cell of a Live Vertebrate Animal
  • Lysosomal Enhancement Strategies in Dopaminergic Neurodegeneration
  • MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control
  • MeCP2 Modulation of BDNF Signaling: Shared Mechanisms of Rett and Autism
  • Measuring Neuroinflammation in Chronic Fatigue Syndrome with Whole-brain Magnetic Resonance Spectroscopy
  • Mechanisms for Tau Involvement in Alzheimer's Disease
  • Mechanisms for the Benefit of Tau Reduction in Alzheimer Disease Models
  • Mechanisms of Age-Dependent Nigral Neuron Loss in PINK1 Knockout Rats
  • Mechanisms of Alpha-synuclein Mediated Inflammation in Multiple System Atrophy
  • Mechanisms of Dysbindin Abnormalities in Schizophrenia
  • Mechanisms of Frontotemporal Dementia Like Behavior in Progranulin Deficient Mice
  • Mechanisms of LRRK2 Mediated Neurotoxicity
  • Mechanisms of LRRK2 Mediated Neurotoxicity
  • Mechanisms of Protection Against Age-Dependent Nigral Neuron Loss in DJ-1 KO Rats
  • Methods to Reduce HD Gene Expression
  • Mitochondrial Bioenergetic Dysfunction and Chlorine Toxicity
  • Modeling Low-grade Gliomas Using Human Pluripotent Stem Cells
  • Molecular Characterization of Neural Stem Cell Apoptosis
  • Molecular Signatures of Amyotrophic Lateral Sclerosis in Skeletal Muscle
  • Multidimensional Neuroimaging Investigation of Posttraumatic Stress in Humans
  • NF-kB Methyl-Lysine Signaling in the Epigenetic Regulation of Memory
  • Na/Bicarbonate Cotransporters in Brain
  • Neocortical Epilepsy During Development
  • Network of Excellence in Neuroscience Clinical Trials (NEXT)
  • Network of Excellence in Neuroscience Clinical Trials (NEXT)
  • New GAA Expansion Mouse for Efficacy Studies of Treatments for Friedreich Ataxia
  • New Nonsense Suppression Drugs to Treat MPS I
  • Newborn Neurons In The Adult Hippocampal Network
  • Newborn Neurons in the Adult Hippocampal Network
  • Newborn Neurons in the Adult Hippocampal Network
  • Newborn Neurons in the Adult Hippocampal Network
  • Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson’s Disease
  • O-GlcNAcylation Dampens Hyperexcitability in Hippocampus during Acute Epileptiform Activity
  • O-GlcNAcylation and Hippocampal Synaptic Plasticity
  • O-Linked Glycosylation and Synaptic Function in Hippocampus
  • PGC-1alpha and GABAergic Dysfunction in Huntington Disease
  • Paracrine Signaling in Glioma: Bioenergetics Heterogeneity and Chemoresistance
  • Passive Eye Response as a Surrogate for Brain Response to Head Acceleration
  • Pharmacogenomics of Parkinson's Disease
  • Poly (ADP-ribose) Mediates Cell Death in Stroke by Inhibiting Glucose Metabolism
  • Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
  • Presynaptic NMDA Receptors and GABA Release in Cortical Dysplasia
  • Preventing Epilepsy using Vigabatrin in Infants with Tuberous Sclerosis Complex
  • Properties and Function of Glia Ion Channels
  • Quality of Epilepsy Treatment and Costs in Older Americans by Race (QUIET CARE)
  • Radiation-Induced Crosstalk of Immune and Glioma Stem Cells
  • Rapid modulation of hippocampal GABAergic Inhibition by O-GlcNAcylation
  • Regulation of Alpha Synuclein Release and Toxicity by Rab27b
  • Regulation of CIC-3 in Human Malignant Glioma
  • Regulation of Cellular Release of Proteins in Parkinson's Neurodegeneration
  • Regulation of the Vasculature by Invading Glioma Cells
  • Role of 14-3-3 Proteins in Alpha-Synuclein-Induced Neurotoxicity
  • Role of Alpha Synuclein in PINK1-linked Parkinson's Disease
  • Role of CL-Channels and Transporters in Tumor-Associated Epilepsy
  • Role of Complement in Alpha-Synuclein Based Models of Parkinson Disease
  • Role of Dentate Gryrus Gating and Neurogenesis in the Pathophysiology of Mild TBI
  • Role of MicroRNAs in Modulating Inflammation in Alpha-Syn Mediated Models of PD
  • Role of Microglial LRRK2 in Inflammation
  • Role of Presynaptic Targeting of Alpha-Synuclein in the Pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies
  • Role of T cells in an Alpha-Synuclein Mediated Mouse Model of Parkinson Disease
  • Smad Signaling in Skeletal Muscle as a Biomarker of Disease Progression in ALS
  • StrokeBelt StrokeNet
  • Subcellular Localization of Glutamate Spillover on to Inhibitory Interneurons in the Cerebellar Cortex
  • Suppression of the Idua-W402X Mutation in an MPS I-H Mouse
  • TRADD as a Regulator of Cytokine Signaling in Glia
  • Targeting MELK-Mediated EZH2 Signaling in Glioma Stem Cells
  • Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma
  • The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients
  • The Nigral Molecular Clock and Vulnerability to Neurodegeneration
  • The Role of Astrocytes in Huntington's Disease
  • The Role of Cdk5 in Stroke
  • The Role of ESCRTs in Regulating Nervous System Function
  • The Role of HIV Tat-Induced SOCS3 in HIV Associated Dementia
  • The Role of HuR in Mutant SOD1 Dysregulation of VEGF mRNA Processing
  • The Role of Ion Transport in Glioma Cell Migration, Proliferation and Apoptosis
  • The Role of Usp 14 in Regulating Neuronal Function
  • The Role of the Terminal Complement Pathway in ALS
  • Therapeutic Intervention of Lewisite-Mediated Cutaneous Blistering-Inflammation
  • Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation
  • Thymectomy in Non-Thymomatous MG Patients on Prednisone
  • Thymectomy in Non-Thymomatous MG Patients on Prednisone
  • Timing of Neurotransmitter Release
  • Timing of Neurotransmitter Release
  • Training Program in Brain Tumor Biology
  • Training Program in Brain Tumor Biology
  • Training Program in the Neurobiology of Cognition and Cognitive Disorders
  • Training Program in the Neurobiology of Cognition and Cognitive Disorders
  • Training Program in the Neurobiology of Cognition and Cognitive Disorders
  • Training Program in the Neurobiology of Cognition and Cognitive Disorders
  • Transcriptional Regulation of Metabolism in Neurons
  • UAB Neuroscience Core Center
  • UAB Neuroscience Core Center
  • UAB Neuroscience Core Center
  • UAB Neuroscience Core Center - Core A
  • UAB Neuroscience Core Center - Core A
  • UAB Neuroscience Core Center - Core A: Behavioral Assessment Core
  • UAB Neuroscience Core Center - Core B
  • UAB Neuroscience Core Center - Core B
  • UAB Neuroscience Core Center - Core B: Molecular Detection and Stereology Core
  • UAB Neuroscience Core Center - Core C
  • UAB Neuroscience Core Center - Core C
  • UAB Neuroscience Core Center - Core C: Vector and Virus Core
  • UAB Neuroscience Core Center - Core D
  • UAB Neuroscience Core Center - Core D: Administrative Core
  • UAB Neuroscience Roadmap Scholars Program
  • UAB Neurroscience Core Center - Core D
  • UAB PD Neuroprotection Clinical Trial Center
  • UAB Parkinson's Disease Neuroprotection Clinical Trial Center
  • UAB Pre and Post-Doctoral Training Program in Biostatistics
  • UAB Research and Education Program in Neurology, Neurosurgery, and Neuropathology
  • UAB Research and Education Program in Neuroscience
  • UAB Training Program in Neuroscience
  • Understanding Hippocampal Internal Architecture in Human Temporal Lobe Epilepsy -- From MRI to Epigenetics
  • Using a Humanized Microbiome Mouse Model to Assess Therapeutic Response in Glioblastoma
  • VCID and Stroke in Bi-Racial National Cohort
  • VCID and Stroke in a Bi-racial National Cohort
  • Validating the NIH Toolbox in the Acute Neurorehabilitation Setting
  • Vascular Biology of the Human Blood-Nerve Barrier
  • fMRI of Language Recover Following Stroke in Adults